# Impact of Clinician-administered Vaginal Live Biotherapeutic Product

> **NCT07305844** · EARLY_PHASE1 · ENROLLING_BY_INVITATION · sponsor: **Caroline Mitchell** · enrollment: 71 (estimated)

## Conditions studied

- Bacterial Vaginosis

## Interventions

- **DRUG:** LC106

## Key facts

- **NCT ID:** NCT07305844
- **Lead sponsor:** Caroline Mitchell
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2026-04-28
- **Primary completion:** 2026-06-30
- **Final completion:** 2026-06-30
- **Target enrollment:** 71 (ESTIMATED)
- **Last updated:** 2026-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07305844

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07305844, "Impact of Clinician-administered Vaginal Live Biotherapeutic Product". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT07305844. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*